Post-transfusion–graft-versus-host disease (PT-GVHD) is a rare complication of blood transfusion. A 54-year-old male patient went through surgery for intracranial tumour (meningioma in right hemisphere) developed after blood trasfusion fever and erythematous maculopapular rush, with subsequent hepatic and intestinal disease and serious diarrhoea. Intravenous immunoglobulins (IVIG) was administered daily at a dose 0.5 g/kg body weight for five consecutive days.
Orlandi, C., Frassetto, A., Gnucci, E., Lehmann, J.R., Neri, R., Melandri, D. (2006). Treatment of acute post-transfusion - Graft-versus-host disease (GVHD) with intravenous human immunoglobulins: A case report [18]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 20(6), 760-761 [10.1111/j.1468-3083.2006.01537.x].
Treatment of acute post-transfusion - Graft-versus-host disease (GVHD) with intravenous human immunoglobulins: A case report [18]
Frassetto A.;Lehmann J. R.;Melandri D.
2006
Abstract
Post-transfusion–graft-versus-host disease (PT-GVHD) is a rare complication of blood transfusion. A 54-year-old male patient went through surgery for intracranial tumour (meningioma in right hemisphere) developed after blood trasfusion fever and erythematous maculopapular rush, with subsequent hepatic and intestinal disease and serious diarrhoea. Intravenous immunoglobulins (IVIG) was administered daily at a dose 0.5 g/kg body weight for five consecutive days.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
